Secukinumab for children and adolescents with enthesitis-related arthritis and psoriatic arthritis: lessons from treatment in adults and the way forward,Expert Review of Clinical Immunology

当前位置： X-MOL 学术 › Expert Rev. Clin. Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Secukinumab for children and adolescents with enthesitis-related arthritis and psoriatic arthritis: lessons from treatment in adults and the way forward
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2024-01-10 , DOI: 10.1080/1744666x.2024.2303340
Narendra Kumar Bagri ₁ , Hayley King ₂ , A. V. Ramanan _{2,

3}

Affiliation

Targeting IL-17A using Secukinumab, a humanized monoclonal immunoglobulin G1 (IgG1)/κ against IL-17A is a therapeutic option for immune-mediated disorders such as psoriasis and ankylosing spondylit...

中文翻译：